The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
12 02 2020
Historique:
received: 16 01 2020
revised: 07 02 2020
accepted: 07 02 2020
entrez: 16 2 2020
pubmed: 16 2 2020
medline: 17 2 2021
Statut: epublish

Résumé

As the biology of mesenchymal stromal cells (MSCs) in patients with non-malignant hematological diseases (NMHD) is poorly understood, in the current study we performed a basic characterization of the phenotype and functional activity of NMHD-MSCs. Bone marrow (BM) of patients with thalassemia major (TM) possessed a significantly higher number of nucleated cells (BM-MNCs)/mL BM than healthy donors (

Identifiants

pubmed: 32059574
pii: cells9020431
doi: 10.3390/cells9020431
pmc: PMC7072753
pii:
doi:

Substances chimiques

CD146 Antigen 0
Dinoprostone K7Q1JQR04M
Indomethacin XXE1CET956

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Blood. 2009 Jun 25;113(26):6576-83
pubmed: 19398717
J Arthroplasty. 2015 Sep;30(9):1506-1512.e5
pubmed: 25900167
Stem Cells. 2017 May;35(5):1416-1430
pubmed: 28233425
Int J Lab Hematol. 2011 Jun;33(3):281-9
pubmed: 21199425
Open Orthop J. 2008 Apr 25;2:62-5
pubmed: 19478932
Mol Ther. 2015 Jul;23(7):1248-1261
pubmed: 25899824
J Immunol Res. 2015;2015:284215
pubmed: 25918734
Blood. 2012 Jan 5;119(1):296-307
pubmed: 22010102
Stem Cells Dev. 2012 Jul 20;21(11):2000-11
pubmed: 22214206
Stem Cells Dev. 2011 Aug;20(8):1309-18
pubmed: 21047210
Exp Cell Res. 2010 Nov 15;316(19):3109-23
pubmed: 20804749
J Clin Oncol. 2000 Jan;18(2):307-16
pubmed: 10637244
J Cell Physiol. 1996 Mar;166(3):585-92
pubmed: 8600162
Leukemia. 2008 Nov;22(11):2054-61
pubmed: 18719618
J Adv Res. 2015 May;6(3):449-58
pubmed: 26257943
Biol Blood Marrow Transplant. 2005 May;11(5):389-98
pubmed: 15846293
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
Blood. 1983 Nov;62(5):941-64
pubmed: 6354307
Stem Cell Res. 2009 Jan;2(1):83-94
pubmed: 19383412
Stem Cell Res. 2015 Nov;15(3):584-594
pubmed: 26492634
Am J Hematol. 2011 Sep;86(9):806-8
pubmed: 21850660
J Cell Physiol. 1998 Jul;176(1):57-66
pubmed: 9618145
Stem Cell Res Ther. 2015 May 29;6:110
pubmed: 26021713
J Clin Invest. 2019 Feb 25;129(4):1566-1580
pubmed: 30830876
Blood. 2017 Mar 16;129(11):1548-1556
pubmed: 27965196
Hematology. 2018 Jan;23(1):44-49
pubmed: 28581352
Ann Hematol. 2010 Jul;89(7):715-23
pubmed: 20084382
Sci Rep. 2017 Feb 22;7:43003
pubmed: 28223693
Hematol Oncol Clin North Am. 2013 Feb;27(1):1-17, vii
pubmed: 23351985
Lancet. 2008 May 10;371(9624):1579-86
pubmed: 18468541
Br J Haematol. 2015 Jun;169(6):804-13
pubmed: 25819548
Blood. 2004 Aug 1;104(3):895-903
pubmed: 15090447
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Blood. 2011 May 12;117(19):5067-77
pubmed: 21415267
Biol Blood Marrow Transplant. 2015 May;21(5):934-40
pubmed: 25659882
Blood. 2015 Oct 15;126(16):1885-92; quiz 1970
pubmed: 26185129
PLoS One. 2012;7(11):e47764
pubmed: 23144828
Stem Cells Int. 2014;2014:276862
pubmed: 24876847
Blood. 2005 Feb 15;105(4):1815-22
pubmed: 15494428
Fetal Pediatr Pathol. 2014 Feb;33(1):9-15
pubmed: 24070195
Haematologica. 2014 Jul;99(7):1168-75
pubmed: 24727813
Bone Marrow Transplant. 2017 May;52(5):704-710
pubmed: 28067873
Br J Haematol. 2015 Sep;170(6):826-36
pubmed: 26010568
Nature. 2009 Jul 9;460(7252):259-63
pubmed: 19516257
Biol Blood Marrow Transplant. 2011 Sep;17(9):1375-82
pubmed: 21277376
Cytotherapy. 2016 Sep;18(9):1197-208
pubmed: 27424149
Biol Blood Marrow Transplant. 2017 May;23(5):736-745
pubmed: 28132869
Med Hypotheses. 1988 Apr;25(4):209-17
pubmed: 3285144
Bone. 2012 Jan;50(1):325-30
pubmed: 22094904
Pediatr Blood Cancer. 2018 Apr;65(4):
pubmed: 29286549
Am J Stem Cells. 2012 Jun 30;1(2):138-145
pubmed: 23087846

Auteurs

Zyrafete Kuci (Z)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Christiane Jordan (C)

Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen GmbH, Goethe University Hospital, 60528 Frankfurt am Main, Germany.

Sibylle Wehner (S)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Jan Sörensen (J)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Andrea Jarisch (A)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Emilia Salzmann-Manrique (E)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Lisa-Marie Pfeffermann (LM)

Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen GmbH, Goethe University Hospital, 60528 Frankfurt am Main, Germany.

Thomas Klingebiel (T)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Peter Bader (P)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Selim Kuҫi (S)

University Hospital for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt am Main, 60528 Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH